Colorectal cancer
Conditions
Interventions
Case series:Nil
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed as colorectal cancer by histopathology; 2. ECOG score 0-2 points; 3. Need to receive Ankeda drug therapy (single drug or combination therapy).
Exclusion criteria
Exclusion criteria: 1. Patients with severe bleeding or recent hemoptysis (>=1/2 teaspoon of fresh blood); 2. Patients with uncontrolled hypertension and hypertensive crisis; 3. Those who are planning to undergo major traumatic surgery within 4 weeks before administration, or during the study period, or whose wounds are not fully healed within 4 weeks before administration; 4. Patients who have a perforation or fistula of the digestive tract in the past, or who have experienced a perforation or fistula after using bevacizumab; 5. Women who are pregnant or breastfeeding, and men and women who refuse to take effective contraceptive measures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective Response Rate; | — |
Countries
China
Contacts
Public ContactHaiping Zheng
Department of Oncology, the First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed